PMDA drug package insert
パロノセトロン静注0.75mg/5mL「タイホウ」
PMDA Prescription drug · 岡山大鵬薬品株式会社 · package insert Apr 28, 2026
Key facts
| Brand names | パロノセトロン静注0.75mg/5mL「タイホウ」, パロノセトロン点滴静注バッグ0.75mg/50mL「タイホウ」 |
|---|---|
| Nonproprietary names | パロノセトロン塩酸塩 |
| Companies | 製造販売元／岡山大鵬薬品株式会社, 提携先／HELSINN |
| Product type | Prescription drug |
| Therapeutic category | 5-HT3受容体拮抗型制吐剤 |
| Therapeutic category codes | 872391 |
| YJ codes | 2391404A1038, 2391404G1030 |
| Approval numbers | 30300AMX00183000, 30300AMX00182000 |
| Package insert edition | 第3版 |
| Package insert date | Apr 28, 2026 |
| PMDA document key | 340264_2391404A1038_1 |
| PMDA company code | 340264 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: